[PDF][PDF] Seroprevalence of human T-cell lymphotropic virus-1/2 in blood donors in northern Pakistan: implications for blood donor screening

SK Niazi, FA Bhatti, N Salamat - J coll physicians surg Pak, 2015 - academia.edu
Objective: To determine the seroprevalence of Human T-cell Lymphotropic Virus-1/2 (HTLV-
1/2) in blood donors in Northern Pakistan. Study Design: Descriptive study. Place and …

Phylogenetic Analysis and Frequency Estimation of HTLV-1 Virus in Hemophilic Patients Refer to Iranian Comprehensive Hemophilia Care Center (ICHCC)

T Taikandi, N Momenifar, A Namvar, AA Saraji… - Molecular Genetics …, 2023 - Springer
Human T-lymphotropic virus type 1 (HTLV-1) is associated with the development of
malignant diseases, particularly adult T-cell leukemia/lymphoma (ATLL) and …

Seroprevalence study of HTLV-1 and 2 in prospective blood donors and pregnant women in Port Harcourt, Nigeria.

C Iyalla, AO Ejele, DA Okoh, E Igbigbi - African Journal of Infectious …, 2015 - ajol.info
Background: Infection with Human T-cell Lymphotropic virus type 1 and 2 (HTLV-1/2) is a
global epidemic. Nigeria is in the endemic region of HTLV-1/2 infections. The diseases …

Seroprevalence of human T-cell lymphoma/leukemia virus type-1 (HTLV-1) antibodies among blood donors at Enugu, Nigeria

AE Okoye, OG Ibegbulam, RC Onoh… - Journal of blood …, 2015 - Taylor & Francis
Background Human T-cell lymphotrophic/leukemia virus (HTLV-1) is a retrovirus implicated
in transfusion-transmitted infection. Objective The objective of this study was to determine …

Human T-lymphotropic virus-1/2 detected in drug abused men who have sex with men in Surakarta Indonesia

AA Prasetyo, Y Sari - AIP Conference Proceedings, 2017 - pubs.aip.org
Human T-cell lymphotropic virus types 1 and 2 (HTLV-1/2) are retroviruses that probably
among the most neglected blood-borne pathogens. The molecular epidemiology data of …

Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki

S Chiyoda, K Kinoshita, S Egawa, J INOUE… - Internal …, 2001 - jstage.jst.go.jp
Decline in the Positive Rate of HumanT-Lymphotropic Virus iype-1 (HTLV-1) Antibodies
amongBlood Donors in Nagasaki Page 1 ORIGINAL ARTICLE Decline in the Positive Rate of …

[HTML][HTML] Comparison of HTLV-I proviral load in adult T cell leukemia/lymphoma (ATL), HTLV-I-associated myelopathy (HAM-TSP) and healthy carriers

MM Akbarin, H Rahimi, T HassanNia… - Iranian Journal of …, 2013 - ncbi.nlm.nih.gov
Objective (s): Human T Lymphocyte Virus Type one (HTLV-I) is a retrovirus that infects about
10-20 million people worldwide. Khorasan province in Iran is an endemic area. The majority …

Molecular detection of HTLV-1 provirus from DNA released from cells in plasma, in cases of lack of access to genomic DNA of peripheral blood mononuclear cells

M Masoudi, Z Sharifi, M Maghsudlu - Scientific Journal of Iran Blood …, 2024 - bloodjournal.ir
Materials and Methods In this descriptive study, 30 HTLV-1 positive Western blot donors
were evaluated. Using an extraction kit, genomic DNA was extracted from plasma and …

[PDF][PDF] A pilot Seroepidemiologic study of HTLV in thalassemia, hemophilia, and hemodialysed patients in Hormozgan

F Abedi, M Yavarian, A Shakibzadeh, B Khalvati… - HMJ, 2009 - hmj.hums.ac.ir
Introduction: Transmission of blood borne infections is common among the multitransfusion
patients such as Thalassemia, Hemophilia and Hemodialysis patients. Human T …

[HTML][HTML] Malignant diseases and mortality in blood donors infected with human T-lymphotropic virus type 1 in Israel

S Stienlauf, V Yahalom, E Shinar, Y Sidi… - International Journal of …, 2013 - Elsevier
Objectives The natural history of blood donors infected with human T-lymphotropic virus type
1 (HTLV-1) in Israel has never been assessed. The aim of this study was to evaluate the …